Best evidence statement (BESt). Oral anxiolytic medication prior to ambulatory healthcare encounters for individuals with special developmental and behavioral challenges. Cincinnati Children's Hospital Medical Center. NGC:008546
- Publication Details
-
- Author(s):
-
- AHRQ (US) - Agency for Healthcare Research and Quality
- Country(ies) of application:
-
- United States
- Language(s):
-
- English
- Type of Publication:
- Guideline Clearing Report
- Primary Contact:
-
Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov - Publication URL:
- Open Publication URL in a new window
- Publication Scope:
-
- Management
- Publication Status:
- Published
- Date of publication:
- Mar 10, 2011
- Due for Review:
- -
- Diseases / Conditions Addressed
-
- MeSH Terms addressed:
-
- Mental Disorders (F03)
-
Pharmacologic Actions (D27.505)
- Central Nervous System Agents (D27.505.954.427)
-
Behaviour and Behaviour Mechanisms (F01)
- Child Behaviour (F01.145.179)
- Behavioral Symptoms (F01.145.126)
- Health Services (N02.421)
- Pediatrics (G02.403.776.610)
- Guideline key questions






